CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
Kaass Discovery is developing a home-use device called ‘a-Doc’ that allows patients with autoimmune diseases to monitor their disease activity using a saliva sample. This innovative solution leverages Artificial Intelligence and a specific biomarker to provide accurate, real-time feedback, enabling better self-manageme…
600m people globally suffer from autoimmune diseases such as rheumatoid arthritis (RA), psoriasis, and multiple sclerosis.
The symptoms can be severe, causing intense pain and suffering for patients.
The cost of RA alone for Europe is €45.3 billion p.a.A growing need:
Unlike diabetes patients for example who can measure their own blood sugar levels, there is currently no method to measure disease activity quickly and accurately for autoimmune patients, non-invasively at home.
Furthermore, most a…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
